Activation of GSK-3β is presumed to be involved in various neurodegenerative diseases, including Alzheimer's disease (AD), which is characterized by memory disturbances during early stages of the disease. The gene discussed is GSK3B; the disease is early-onset autosomal dominant Alzheimer disease.